Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMI MultiStem in NSTEMI
NCT02277613Phase 2Terminated
- Sponsor
- Healios
- Start
- Dec 2015
- Primary completion
- Jun 2019
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of invimestrocel in non-ST-elevation myocardial infarction (NSTEMI), sponsored by Healios. Started Dec 2015; status: terminated.
02
Drugs
invimestrocel
03
Conditions
non-ST-elevation myocardial infarction (NSTEMI)
Beyond the preview
Go deeper on NCT02277613.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02277613.